NCT00990626已完成不适用
Seroquel XR in Schizophrenia Relapse Prevention
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 1,600
- 试验地点
- 1
- 主要终点
- Rate of patients remained relapse free after 6 months of treatment
研究概览
简要总结
The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improve the relapse prevention in schizophrenic outpatients
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Schizophrenic outpatients on at least 600 mg Seroquel XR treatment for at least 1 month
排除标准
- •Severe cerebro- and cardiovascular disease, severe hepatic impairment, gravidity
结局指标
主要结局
Rate of patients remained relapse free after 6 months of treatment
次要结局
- Adherence rate of patients
- Quality of Life (QoL )
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Seroquel XR in the Long Term Treatment of SchizophreniaRelapse in SchizophreniaNCT01202617AstraZeneca1,606
终止
3 期
Seroquel XR in Adults With SchizophreniaSchizophreniaNCT00852631AstraZeneca28
终止
4 期
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current TherapyAcute Bipolar ManiaNCT01128114AstraZeneca32
已完成
不适用
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With SchizophreniaSchizophreniaNCT01212575AstraZeneca186
已完成
不适用
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With SchizophreniaSchizophreniaNCT01214135AstraZeneca300